21490 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds Peptides, e.g. proteins
Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy
#302Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
#303Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules
#304Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis
#305Labelled glutamine and lysine analogues
#306Bioactivated diagnostic imaging contrast agents
#307Amphiphilic polymers and methods of use thereof
#308Lectin conjugates
#309Specific high-relaxivity compounds
#310Gastrin releasing peptide compounds
#311Peptide conjugate for magnetic resonance imaging
#312Optically pure and enriched isomers of chelating ligands and contrast agents
#313Compounds for targeting endothelial cells, compositions containing the same and methods for their use
#314Cupredoxin derived transport agents and methods of use thereof
#315Ligands to radiation-induced molecules
#316Contrast enhancement agent for magnetic resonance imaging
#317Method for convection enhanced delivery of therapeutic agents
#318Enhanced ligand binding to neurotensin receptors
#319Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
#320Peptides whose uptake by cells is controllable
#321Peptide-based multimeric targeted contrast agents
#322Blood brain barrier permeation peptides
#323Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#324Methods for magnetic resonance imaging
#325Method and product for locating an internal bleeding site
#326Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells
#327Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gbexpressing tumors
#328Imaging damaged lung tissue using compositions
#329Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
#330Biochemically-activated contrast agents for magnetic resonance imaging
#331Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage
#332Self-etching emulsion dental compositions and methods
#333Self-adhesive dental compositions and methods
#334Self-etching dental compositions and methods
#335Immunogenic peptides and uses thereof
#336Fluorinated carbohydrate conjugates
#337Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
#338DNA-dependent MRI contrast agents
#339Amino acid composition with increased blood brain barrier permeability
#340Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
#341Peptide-based multimeric targeted contrast agents
#342Methods of cardiothoracic imaging - (MET-30)
#343Target-specific activatable polymeric imaging agents
#344Matrix metalloproteinase inhibitors
#345Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death
#346Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
#347Magnetic resonance imaging agents for the detection of physiological agents